Opus Genetics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.9M | $26.1M | $24.5M |
| FY2022 | $2.8M | $49.0M | $42.6M |
| FY2023 | $4.0M | $53.9M | $50.5M |
| FY2024 | $11.3M | $36.9M | $30.3M |
| FY2025 | $34.9M | $50.2M | $45.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $3.9M | $26.1M | $24.5M |
| FY2022 | $2.8M | $49.0M | $42.6M |
| FY2023 | $4.0M | $53.9M | $50.5M |
| FY2024 | $11.3M | $36.9M | $30.3M |
| FY2025 | $34.9M | $50.2M | $45.1M |